Market Tracker

02/22 3:07am ET

Nektar Therapeutics (NASDAQ:NKTR)

13.41
Delayed Data
As of Feb 21
 +0.31 / +2.37%
Today’s Change
10.52
Today|||52-Week Range
19.98
+9.29%
Year-to-Date
No recent news for Nektar Therapeutics.

Today’s Trading

Previous close13.10
Today’s open13.13
Day’s range12.98 - 13.42
Volume938,832
Average volume (3 months)1,562,659
Market cap$2.0B
Dividend yield--
Data as of 4:00pm ET, 02/21/2017

Growth & Valuation

Earnings growth (last year)-45.24%
Earnings growth (this year)-81.97%
Earnings growth (next 5 years)-7.38%
Revenue growth (last year)+14.99%
P/E ratioNM
Price/Sales9.67
Price/Book275.67

Competitors

 Today’s
change
Today’s
% change
ONCESpark Therapeutics I...+0.22+0.34%
RDUSRadius Health Inc-1.84-4.03%
EXASExact Sciences Corp+2.50+12.56%
AVXSAveXis Inc+0.23+0.39%
Data as of 4:00pm ET, 02/21/2017

Financials

Next reporting dateMarch 7, 2017
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$230.8M
Annual profit (last year)-$81.2M
Net profit margin-35.17%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Operating Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts